General Information of the Compound
| Compound ID |
CP0434404
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-N4-(3-(trifluoromethyl)benzyl)-N1-(2-(dimethylamino)ethyl)-2-((3S,4R)-2-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)-4-((E)-styryl)azetidin-1-yl)succinamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C36H38F3N5O5
|
||||||||||||||||||
| Molecular Weight |
677.724
|
||||||||||||||||||
| Canonical SMILES |
CN(C)CCNC(=O)[C@H](CC(=O)NCc1cccc(c1)C(F)(F)F)N1[C@H](\C=C\c2ccccc2)[C@H](N2[C@H](COC2=O)c2ccccc2)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C36H38F3N5O5/c1-42(2)19-18-40-33(46)29(21-31(45)41-22-25-12-9-15-27(20-25)36(37,38)39)43-28(17-16-24-10-5-3-6-11-24)32(34(43)47)44-30(23-49-35(44)48)26-13-7-4-8-14-26/h3-17,20,28-30,32H,18-19,21-23H2,1-2H3,(H,40,46)(H,41,45)/b17-16+/t28-,29+,30-,32+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VUNPWRICHRMRNX-QLTDWMCJSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound